Viking Therapeutics, Inc. (VKTX)
NASDAQ·Healthcare·Biotechnology
$32.79
-0.61%
Mkt Cap $3.80B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 11, 2026 | $1.92M | — | — | -$0.89 | -$1.38 | -55.06% | — | — |
| Q4 2025 Oct 22, 2025 | — | — | — | -$0.70 | -$0.81 | -15.71% | — | — |
| Q3 2025 Jul 23, 2025 | — | — | — | -$0.44 | -$0.58 | -31.82% | — | — |
| Q2 2025 Apr 23, 2025 | — | — | — | -$0.34 | -$0.41 | -20.59% | — | — |
| Q1 2025 Feb 5, 2025 | — | — | — | -$0.28 | -$0.32 | -14.29% | — | — |
| Q4 2024 Oct 23, 2024 | — | — | — | -$0.24 | -$0.22 | +8.33% | — | — |
| Q3 2024 Jul 24, 2024 | — | — | — | -$0.26 | -$0.20 | +23.08% | — | — |
| Q2 2024 Apr 24, 2024 | — | — | — | -$0.27 | -$0.26 | +3.70% | — | — |
| Q1 2024 Feb 7, 2024 | — | $436.00K | — | -$0.25 | -$0.25 | +0.00% | — | — |
| Q4 2023 Oct 25, 2023 | — | — | — | -$0.22 | -$0.23 | -4.55% | — | — |
| Q3 2023 Jul 26, 2023 | — | — | — | -$0.21 | -$0.19 | +9.52% | — | — |
| Q2 2023 Apr 26, 2023 | — | — | — | -$0.24 | -$0.25 | -4.17% | — | — |
| Q1 2023 Feb 8, 2023 | — | — | — | -$0.23 | -$0.26 | -13.04% | — | — |
| Q4 2022 Oct 26, 2022 | — | — | — | -$0.23 | -$0.21 | +8.70% | — | — |
| Q3 2022 Jul 27, 2022 | — | — | — | -$0.21 | -$0.23 | -9.52% | — | — |
| Q2 2022 Apr 27, 2022 | — | — | — | -$0.20 | -$0.21 | -5.00% | — | — |
| Q1 2022 Feb 9, 2022 | — | — | — | -$0.19 | -$0.16 | +15.79% | — | — |
| Q4 2021 Nov 3, 2021 | — | — | — | -$0.21 | -$0.17 | +19.05% | — | — |
| Q3 2021 Jul 28, 2021 | — | — | — | -$0.19 | -$0.20 | -5.26% | — | — |
| Q2 2021 Apr 28, 2021 | — | — | — | -$0.18 | -$0.19 | -5.56% | — | — |